Literature DB >> 19277051

Heme-hemopexin complex attenuates neuronal cell death and stroke damage.

Rung-chi Li1, Sofiyan Saleem, Gehua Zhen, Wangsen Cao, Hean Zhuang, Jongseok Lee, Ann Smith, Fiorella Altruda, Emanuela Tolosano, Sylvain Doré.   

Abstract

Hemoproteins undergo degradation during hypoxic/ischemic conditions, but the pro-oxidant free heme that is released cannot be recycled and must be degraded. The extracellular heme associates with its high-affinity binding protein, hemopexin (HPX). Hemopexin is shown here to be expressed by cortical neurons and it is present in mouse cerebellum, cortex, hippocampus, and striatum. Using the transient ischemia model (90-min middle cerebral artery occlusion followed by 96-h survival), we provide evidence that HPX is protective in the brain, as neurologic deficits and infarct volumes were significantly greater in HPX(-/-) than in wild-type mice. Addressing the potential protective HPX cellular pathway, we observed that exogenous free heme decreased cell survival in primary mouse cortical neuron cultures, whereas the heme bound to HPX was not toxic. Heme-HPX complexes induce HO1 and, consequently, protect primary neurons against the toxicity of both heme and pro-oxidant tert-butyl hydroperoxide; such protection was decreased in HO1(-/-) neuronal cultures. Taken together, these data show that HPX protects against heme-induced toxicity and oxidative stress and that HO1 is required. We propose that the heme-HPX system protects against stroke-related damage by maintaining a tight balance between free and bound heme. Thus, regulating extracellular free heme levels, such as with HPX, could be neuroprotective.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19277051      PMCID: PMC6015738          DOI: 10.1038/jcbfm.2009.19

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  41 in total

1.  Protein identification in cerebrospinal fluid using packed capillary liquid chromatography Fourier transform ion cyclotron resonance mass spectrometry.

Authors:  Margareta Ramström; Magnus Palmblad; Karin E Markides; Per Håkansson; Jonas Bergquist
Journal:  Proteomics       Date:  2003-02       Impact factor: 3.984

2.  Identification of proteins in human cerebrospinal fluid using liquid-phase isoelectric focusing as a prefractionation step followed by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionisation mass spectrometry.

Authors:  P Davidsson; S Folkesson; M Christiansson; M Lindbjer; B Dellheden; K Blennow; A Westman-Brinkmalm
Journal:  Rapid Commun Mass Spectrom       Date:  2002       Impact factor: 2.419

3.  Induction of inducible heme oxygenase (HO-1) in the central nervous system: is HO-1 helpful or harmful?

Authors:  Y Matsuoka; M Okazaki; Y Kitamura
Journal:  Neurotox Res       Date:  1999-12       Impact factor: 3.911

4.  Heme-hemopexin-mediated induction of metallothionein gene expression.

Authors:  J Alam; A Smith
Journal:  J Biol Chem       Date:  1992-08-15       Impact factor: 5.157

5.  Changes in expression and localization of hemopexin and its transcripts in injured nervous system: a comparison of central and peripheral tissues.

Authors:  L Camborieux; N Bertrand; J P Swerts
Journal:  Neuroscience       Date:  1998-02       Impact factor: 3.590

6.  Defective recovery and severe renal damage after acute hemolysis in hemopexin-deficient mice.

Authors:  E Tolosano; E Hirsch; E Patrucco; C Camaschella; R Navone; L Silengo; F Altruda
Journal:  Blood       Date:  1999-12-01       Impact factor: 22.113

7.  Receptor-mediated transport of heme by hemopexin regulates gene expression in mammalian cells.

Authors:  J Alam; A Smith
Journal:  J Biol Chem       Date:  1989-10-25       Impact factor: 5.157

8.  Hemopexin in the human retina: protection of the retina against heme-mediated toxicity.

Authors:  R C Hunt; D M Hunt; N Gaur; A Smith
Journal:  J Cell Physiol       Date:  1996-07       Impact factor: 6.384

9.  Effects of EP1 receptor on cerebral blood flow in the middle cerebral artery occlusion model of stroke in mice.

Authors:  Sofiyan Saleem; Rung-chi Li; Guo Wei; Sylvain Doré
Journal:  J Neurosci Res       Date:  2007-08-15       Impact factor: 4.164

10.  Microarray and large-scale in silico--based identification of genes functionally related to Haptoglobin and/or Hemopexin.

Authors:  Sharmila Fagoonee; Ferdinando Di Cunto; Diego Vozzi; Stefano Volinia; Maurizio Pellegrino; Paolo Gasparini; Lorenzo Silengo; Fiorella Altruda; Emanuela Tolosano
Journal:  DNA Cell Biol       Date:  2006-06       Impact factor: 3.311

View more
  47 in total

1.  Kinetics and specificity of feline leukemia virus subgroup C receptor (FLVCR) export function and its dependence on hemopexin.

Authors:  Zhantao Yang; John D Philips; Raymond T Doty; Pablo Giraudi; J Donald Ostrow; Claudio Tiribelli; Ann Smith; Janis L Abkowitz
Journal:  J Biol Chem       Date:  2010-07-07       Impact factor: 5.157

2.  Control of Oxidative Stress and Inflammation in Sickle Cell Disease with the Nrf2 Activator Dimethyl Fumarate.

Authors:  John D Belcher; Chunsheng Chen; Julia Nguyen; Ping Zhang; Fuad Abdulla; Phong Nguyen; Trevor Killeen; Pauline Xu; Gerry O'Sullivan; Karl A Nath; Gregory M Vercellotti
Journal:  Antioxid Redox Signal       Date:  2016-03-30       Impact factor: 8.401

3.  Targeting heme oxygenase after intracerebral hemorrhage.

Authors:  Jing Chen-Roetling; Xiangping Lu; Raymond F Regan
Journal:  Ther Targets Neurol Dis       Date:  2015-01-03

4.  Systemic hemin therapy attenuates blood-brain barrier disruption after intracerebral hemorrhage.

Authors:  Xiangping Lu; Jing Chen-Roetling; Raymond F Regan
Journal:  Neurobiol Dis       Date:  2014-06-18       Impact factor: 5.996

5.  Neuroprotective role of prostaglandin PGE2 EP2 receptor in hemin-mediated toxicity.

Authors:  Shekher Mohan; Shuh Narumiya; Sylvain Doré
Journal:  Neurotoxicology       Date:  2014-11-13       Impact factor: 4.294

6.  Hemoglobin as a source of iron overload in multiple sclerosis: does multiple sclerosis share risk factors with vascular disorders?

Authors:  Vladimir V Bamm; George Harauz
Journal:  Cell Mol Life Sci       Date:  2014-02-07       Impact factor: 9.261

7.  Hemopexin decreases hemin accumulation and catabolism by neural cells.

Authors:  Jing Chen-Roetling; Wenpei Liu; Raymond F Regan
Journal:  Neurochem Int       Date:  2012-02-07       Impact factor: 3.921

8.  Increased striatal injury and behavioral deficits after intracerebral hemorrhage in hemopexin knockout mice.

Authors:  Lifen Chen; Xuefeng Zhang; Jing Chen-Roetling; Raymond F Regan
Journal:  J Neurosurg       Date:  2010-12-03       Impact factor: 5.115

9.  Hepatic Overexpression of Hemopexin Inhibits Inflammation and Vascular Stasis in Murine Models of Sickle Cell Disease.

Authors:  Gregory M Vercellotti; Ping Zhang; Julia Nguyen; Fuad Abdulla; Chunsheng Chen; Phong Nguyen; Carlos Nowotny; Clifford J Steer; Ann Smith; John D Belcher
Journal:  Mol Med       Date:  2016-07-19       Impact factor: 6.354

10.  Mechanisms of neuroprotection by hemopexin: modeling the control of heme and iron homeostasis in brain neurons in inflammatory states.

Authors:  Peter Hahl; Taron Davis; Cecilia Washburn; Jack T Rogers; Ann Smith
Journal:  J Neurochem       Date:  2013-02-25       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.